Personalized Medicine in Cardiology – Perspective from Different Stakeholders

Welcome and Opening Remarks

Historical Insights: The journey from the first cases of drug-induced QT prolongation to the present-day safety guidelines and ongoing pharmacogenomic research.

Marlene S. Bentestuen, MD, PhD Student, DCA Grant Recipient, Psychosis Research Unit, Aarhus University Hospital Psychiatry, and Dept. of Clinical Medicine, Health, Aarhus University

Clinical Challenges: Examine how drug-induced arrhythmias influence clinical practice and identify gaps in knowledge.

Jacob Tfelt-Hansen, Professor, MD, DMSc, Section of Genetics, Dept. of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen and Dept. of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet

Translational Perspective: Implementing genetic testing – implications for clinical practice, drug development, patient stratification, and patient safety.

Christiane Gasse, Associate Professor, RPharm, Dr.rer. medic., Dip Epid (McGill), Board member of Dansk Selskab for Personlig Medicin (DSPM)

Coffee and refreshments

Patient Voices: How to facilitate user involvement to improve the quality of care and patient safety.

Anne Wettergren Karlsson, post.doc and adviser, Centre for Research in Collaboration with Patients and Carers (ForSa-P), Odense University Hospital, and OPEN, Region of Southern Denmark

Societal Dynamics: Communicating health complexity.

Adam Bencard, Associate Professor, PhD, Dept. of Public Health, Medical Museion and CBMR

Q/A and Panel Discussion

Panel: Jacob Tfelt-Hansen, Christiane Gasse, Anne Wettergren Karlsson and Adam Bencard.

Moderator: Marlene S. Bentestuen

Closing Remarks